UKRAINS'KYI VISNYK PSYKHONEVROLOHII

The Scientific and Practical Journal of Medicine
ISSN 2079-0325(p)
DOI 10.36927/2079-0325
Home » Archive of numbers » 2024 » Volume 32, issue 4 (121) » OUR EXPERIENCE OF USING LIDOCAINE BLOCKADES WITH VITAMIN B12 IN PATIENTS WITH SEVERE FORMS OF TRIGEMINAL NEURALGIA

OUR EXPERIENCE OF USING LIDOCAINE BLOCKADES WITH VITAMIN B12 IN PATIENTS WITH SEVERE FORMS OF TRIGEMINAL NEURALGIA

Authors

Type of Article

  • Scientific Article

In the Section

  • MECHANISMS OF FORMATION AND MODERN PRINCIPLES OF TREATMENT OF NEUROLOGICAL DISORDERS

Key words

Index UDK:
  • 616.833.15-009.7-089

Abstract

  • To estimate the efficacy of lidocaine blockades with vitamin B12 in patients with trigeminalneuralgia (TN) in both short- and long-term perspectives.The study analyzed the treatment of 43 patients with TN using peripheral nerve blocks:12 men (27.91 %) and 31 women (72.07 %); mean age ± sd — 62.60 ± 11.27 years; disease duration — 8.89 ± 7.73 years. The blocks were performed using a mixture of 4.0 ml of 2 % lidocainewith 500 µg of cyanocobalamin (vitamin B12) administered peri-paraneurally. Pain intensity wasassessed using the Visual Analog Scale (VAS) at various time points: from 30 minutes to threeyears after the blockades.Pain intensity at admission ranged from 5.5 to 10 (8.74 ± 1.06) cm on the VAS. Thirty minutesafter the block, it decreased to 2.5—4.5 (2.75 ± 0.65). Due to the return of pain, radical surgicalinterventions were performed in 38 patients. After 6—36 months, excellent and good resultswere achieved in 5 (11.63 %) patients.Lidocaine blockades with vitamin B12 (cyanocobalamin) proved their high short-term efficacy; however, long-term results are achieved in only 11.63 % of patients. Their use is advisableas part of the comprehensive treatment of TN patients.

Pages

  • 47-54

Year / Issue

Download PDF

Bibliography

1. Posokhov M. F. Modern problems in neurosurgical treatment of pharmacoresistant facial pains. Український вісник психоневрології [Ukrainian Bulletin of Psychoneurology]. 2016.Vol. 24, iss. 1 (86). P. 101-103. (In English).
2. Bendtsen L, Zakrzewska JM, Abbott J, Braschinsky M,Di Stefano G, Donnet A, Eide PK, Leal PRL, Maarbjerg S, May A,Nurmikko T, Obermann M, Jensen TS, Cruccu G. European Academyof Neurology guideline on trigeminal neuralgia. Eur J Neurol. 2019 Jun;26(6):831-849. doi: 110.1111/ene.13950. PMID: 30860637.
3. Xu  R, Xie  ME, Jackson CM. Trigeminal Neuralgia: Current Approaches and Emerging Interventions. J Pain Res. 2021Nov 3;14:3437-3463. doi: 10.2147/JPR.S331036. PMID: 34764686;PMCID: PMC8572857.
4. Allam AK, Sharma H, Larkin MB, Viswanathan A. Trigeminal Neuralgia: Diagnosis and Treatment. Neurol Clin. 2023Feb;41(1):107-121. doi: 10.1016/j.ncl.2022.09.001. PMID: 36400550.
5. Headache Classification Committee of the InternationalHeadache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018 Jan;38(1):1-211.doi: 10.1177/0333102417738202. PMID: 29368949.
6. Lee CH, Jang HY, Won HS, Kim JS, Kim YD. Epidemiologyof trigeminal neuralgia: an electronic population health datastudy in Korea. Korean J Pain. 2021 Jul 1;34(3):332-338. doi:10.3344/kjp.2021.34.3.332. PMID: 34193639; PMCID: PMC8255158.
7. Gambeta E, Chichorro JG, Zamponi GW. Trigeminal neuralgia: An overview from pathophysiology to pharmacologicaltreatments. Mol Pain. 2020 Jan-Dec;16:1744806920901890.doi: 10.1177/1744806920901890. PMID: 31908187; PMCID:PMC6985973.
8. Shbeer A. Regional Anesthesia (2012-2021): A Comprehensive Examination Based on Bibliometric Analyses of Hotpots,Knowledge Structure and Intellectual Dynamics. J Pain Res.2022 Aug 15;15:2337-2350. doi: 10.2147/JPR.S372303. PMID:35996451; PMCID: PMC9391991.
9. Kim MJ, Son JY, Ju JS, Ahn DK. Early Blockade of EphA4Pathway Reduces Trigeminal Neuropathic Pain. J  Pain Res.2020 May 22;13:1173-1183. doi: 10.2147/JPR.S249185. PMID:32547180; PMCID: PMC7250313.
10. Ben Aziz M, Cascella M. Peripheral Neurolytic Blocks. 2023Jul 3. In: StatPearls [Internet]. Treasure Island (FL): StatPearlsPublishing; 2024 Jan–. PMID: 32644734.
11. Di Stani F, Ojango C, Dugoni D, Di Lorenzo L, Masala S,Delfini R, Bruti G, Simonetti G, Piovesan EJ, Ruggeri AG. Combination of pharmacotherapy and lidocaine analgesic blockof the peripheral trigeminal branches for trigeminal neuralgia:a pilot study. Arq Neuropsiquiatr. 2015 Aug;73(8):660-4. doi:10.1590/0004-282X20150077. PMID: 26222356.
12. Ikeda K, Iwasaki Y, Kaji R. Neuroprotective effect of ultrahigh dose methylcobalamin in wobbler mouse model of amyotrophic lateral sclerosis. J Neurol Sci. 2015 Jul 15;354(1-2):70-4.doi: 10.1016/j.jns.2015.04.052. Epub 2015 May 8. PMID: 25982504.
13. Посохов М.  Ф. Ефективність лідокаїнових блокаду хворих з тяжкими формами невралгії трійчастого нерва.Posokhov M. F. [Effectiveness of lidocaine blockades in patientswith severe forms of trigeminal neuralgia]. Український вісник психоневрології [Ukrainian Bulletin of Psychoneurology]. 2024.Vol. 32, iss. 3 (120). P. 4-13. DOI: https://doi.org/10.36927/2079-0325-V32-is3-2024-1. (In Ukrainian).
14. Aranha RLB, Resende RG, de Souza FA. Peripheral nerveblocks for acute trigeminal neuralgia involving maxillary andmandibular branches: a case report. J Dent Anesth Pain Med.2023 Dec;23(6):357-362. doi: 10.17245/jdapm.2023.23.6.357.Epub 2023 Nov 27. PMID: 38076503; PMCID: PMC10703551.
15. Miller GH. Advanced Techniques in Trigeminal Neuralgia Treatment: A Comprehensive Guide. New York: Springer, 2019. 354 p.
16. Sung YT, Wu JS. The Visual Analogue Scale for Rating,Ranking and Paired-Comparison (VAS-RRP): A new techniquefor psychological measurement. Behav Res Methods. 2018Aug;50(4):1694-1715. doi: 10.3758/s13428-018-1041-8. PMID:29667082; PMCID: PMC6096654.
17. R Core Team (2021). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna,Austria. URL: https://www.R-project.org/.
18. Balta S, Köknel Talu G. Clinical effectiveness of peripheralnerve blocks with lidocaine and corticosteroid in patients withtrigeminal neuralgia. Agri. 2021 Oct;33(4):237-242. English. doi:10.14744/agri.2021.26032. PMID: 34671954.
19. Thompson V.F. Peripheral Nerve Blocks for Facial Pain:Clinical Practice and Outcomes. Oxford: Oxford University Press,2020. 280 p.
20. Johnson CD, Yi SH., Kim B. et al. Age as a Factor in theEfficacy of Lidocaine Blockades for Trigeminal Neuralgia. PainMedicine. 2018; 19(5):1007-1013.
21. Фишер Ю. Локальное лечение боли. Fisher Yu. [Localtreatment of pain]. M.: MEDpress-inform, 2006. 159 p. (In Russian).
22. Kumar A, Sinha C, Kumar A, Kumari P, Mukul SK. Ultrasound-guided trigeminal nerve block and its comparison withconventional analgesics in patients undergoing faciomaxillary surgery: Randomised control trial. Indian J Anaesth. 2018Nov;62(11):871-875. doi: 10.4103/ija.IJA_256_18. PMID: 30532323;PMCID: PMC6236796.
23. Montano N, Conforti G, Di Bonaventura R, Meglio M, Fernandez E, Papacci F. Advances in diagnosis and treatment of trigeminal neuralgia. Ther Clin Risk Manag. 2015 Feb 24;11:289-99.doi: 10.2147/TCRM.S37592. PMID: 25750533; PMCID: PMC4348120.

Journal’s Indexing:

UKRAINS'KYI VISNYK PSYKHONEVROLOHII

The Scientific and Practical Journal of Medicine

ДУ «ІНПН імені
П.В. ВОЛОШИНА
НАМН УКРАЇНИ»